Bonus BioGroup Ltd. Logo

Bonus BioGroup Ltd.

A clinical-stage biotech firm developing cell therapy and tissue engineering products.

BONS | TA

Overview

Corporate Details

ISIN(s):
IL0004850116
LEI:
Country:
Israel
Address:
Park P.O.B 15143, 31905 Haifa

Description

Bonus BioGroup Ltd. is a clinical-stage biotechnology company that develops cell therapy and tissue engineering products. The company's research focuses on addressing unmet medical needs related to tissue damage, inflammation, and immune response. Its core technology platforms include an investigational cell therapy designed to modulate inflammation and promote tissue repair using mesenchymal cells, and a viable tissue engineering approach that combines patient-derived cells with biomaterials for bone regeneration. Key product candidates in its pipeline are BonoFill, a personalized, tissue-engineered bone graft for orthopedic and maxillofacial defects, and MesenCure, an allogeneic cell therapy developed to target inflammation and tissue damage. These investigational therapies are currently being evaluated in clinical trials for safety and efficacy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-27 11:48
Company Presentation- 2025
Hebrew (modern) 9.0 MB
2025-05-27 11:48
Company Presentation- 2025
Russian 43.6 KB
2023-07-11 12:06
Company Presentation, July 2023
English 3.4 MB
2023-07-11 12:06
Company Presentation, July 2023
Russian 44.7 KB
2022-04-11 16:02
Company Presentation
English 8.2 MB
2022-04-11 16:02
Company Presentation
Russian 47.1 KB
2022-04-11 15:01
Company Presentation
Hebrew (modern) 11.0 MB
2022-04-11 15:01
Company Presentation
Russian 47.1 KB
2022-01-10 10:52
The company inteds to publish an immediate report, trading will be open after …
Hebrew (modern) 105.1 KB

Automate Your Workflow. Get a real-time feed of all Bonus BioGroup Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bonus BioGroup Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bonus BioGroup Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Metagenomi, Inc. Logo
A genetic medicines company developing therapeutics with a genome editing toolbox.
United States of America
MGX
MindWalk Holdings Corp. Logo
A Bio-Native AI company that integrates AI and lab research for drug discovery.
United States of America
HYFT
Mips Logo
Specializes in helmet-based safety technology to redirect rotational motion.
Sweden
MIPS
A think tank offering research, consulting, and ICT solutions for societal issues.
Japan
3636
Modus Therapeutics Holding AB Logo
Clinical-stage biotech developing a polysaccharide for systemic inflammation.
Sweden
MODTX
Molecure S.A. Logo
Clinical-stage biotech developing small molecule drugs for oncology and fibrotic diseases.
Poland
MOC
Monopar Therapeutics Logo
Clinical-stage biotech developing radiopharmaceuticals for oncology and rare diseases.
United States of America
MNPR
Mural Oncology PLC Logo
Clinical-stage biotech developing novel cytokine-based cancer immunotherapies.
Ireland
MURA
N4 PHARMA PLC Logo
Develops a silica nanoparticle delivery system for nucleic acid-based treatments.
United Kingdom
N4P
NanoGroup S.A. Logo
Develops nanotechnology-based medical solutions for oncology and transplantology.
Poland
NNG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.